Search Results for: lawsuit

There is enormous interest in point-of-care for-profit stem cell commercialization by relatively small clinics hoping to hit it big here in the U.S. Some big investors have poured millions into these clinics that are treating patients with adult stem cell therapies. As I’ve talked with some of these folks they expect this market to grow dramatically […]

There has been a long and winding road for a lawsuit against federal funding of embryonic stem cell research (ESCR). The latest phase was an appeal by the plaintiffs (those suing the government to stop federal funding of ESCR) to a U.S. Appeals Court of a decision that went against them in the D.C. Court

In December 2011 I wrote a piece about a possible “perfect storm” of events that could crush stem cell research. Was I being too pessimistic? Now that we are into July 2012 making this fall very much closer on the horizon, how’s the forecast now? That perfect storm if anything seems more likely now. I

The metaformin story is very interesting, but why show picture of Bartolo Colon who got dubious stem cell treatment for arm injury? Some stem cell scientists express concerns about Osiris; see article by Alexey. Sweat gland story is interesting. Stem cells for heart disease is a key, exciting area, but still early days….still definitely one to watch! I have trouble

As I’ve been writing this blog for the last couple years it has served as a catalyst for me to meet dozens of really interesting people. One such person is Lee Buckler, a true stem cell industry guru. Given all the complex events of late in the stem cell field, I asked Lee if he

What does the future hold for the privately-held Texas stem cell clinic, Celltex, that had given Governor Perry a stem cell transplant? I put up a poll a few days ago asking this question and the results have been striking. By way of background, it’s been a complicated few weeks for Celltex. Almost a month ago, I

It’s only Wednesday and it’s already been a big, bumpy week for Texas stem cell company, Celltex. On Monday, the FDA report of their two-week visit to/audit of Celltex became public thanks to the efforts of Dr. Leigh Turner and Houston Chronicle reporter, Todd Ackerman. Now there is more complicated news for the company. A